Crescent Biopharma, Inc. (CBIO) vs MiMedx Group, Inc (MDXG)
- Crescent Biopharma, Inc. CBIO 13.48 +4.17%
- MiMedx Group, Inc MDXG 3.31 +0.91%
Crescent Biopharma, Inc. and MiMedx Group, Inc are both Biotechnology companies. Crescent Biopharma, Inc. and MiMedx Group, Inc are of similar size ($480.6M and $478.6M). MiMedx Group, Inc grew revenue faster over the last twelve months: −22.8% against −45.1%. Crescent Biopharma, Inc. has the higher net margin (0.00% vs −6.32%) and the higher return on invested capital (0.00% vs −17.4%). Across the 17 metrics below, MiMedx Group, Inc leads on 11 and Crescent Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | CBIO | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.72% | 77.29% | 68.51% |
| Operating margin | 0.00% | (8.28%) | 0.00% |
| Net margin | 0.00% | (6.32%) | 0.00% |
| Free cash flow margin | 0.00% | 6.26% | 0.00% |
| Return on equity | (101.95%) | (8.53%) | (51.96%) |
| Return on assets | (88.26%) | (6.58%) | (46.06%) |
| Return on invested capital | 0.00% | (17.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack